CYMP-AS1 Promotes Ovarian Cancer Progression by Enhancing the Intracellular Translocation of hnRNPM and Reducing the Stability of AXIN2 mRNA
This study confirms CYMP-AS1 as a novel biomarker in OC progression and suggests that the CYMP-AS1/hnRNPM/AXIN2 axis may offer an innovative strategy for OC treatment.
Authors
- Yaru Wang (ORCID: https://orcid.org/0000-0003-1734-8487)
- Wei Xia (ORCID: https://orcid.org/0000-0002-4171-5008)
- Yimei Meng
- Lei Fang (ORCID: https://orcid.org/0000-0002-0433-3174)
- Y. Andrew Wang
- Peiling Li (ORCID: https://orcid.org/0009-0007-2906-5130)
- Yusen Liang
Institutions
- Harbin Medical University (CN)
- Second Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.32604/or.2025.064367
- Primary Topic
- RNA Research and Splicing
- Type
- article
- Field-Weighted Citation Impact
- 0.00